In an op-ed published today in the GlobalPost, Sabin executive vice president Ciro de Quadros, M.D., M.P.H., looks back on his work treating communities in Brazil which were once devastated by smallpox and polio.

Op-ed by Dr. Ciro de Quadros- World Pneumonia Day: Past lessons, future progress

November 10, 2011 | GlobalPost

Past lessons, future progress
A guest post by Dr. de Quadros of the Sabin Vaccine Institute on treating pneumonia today

When I think of my early days as the chief medical officer at a small clinic in the Brazilian Amazon, I marvel at how much has been achieved. In the early 1960s, smallpox devastated the lives of families throughout my country, and indeed the world. Similarly, polio inspired widespread panic and fear of life-altering paralysis, especially in the summer when outbreaks were common.

GlobalPost

The Global Network, the Sabin product development partnership (PDP) and Dr. Peter Hotez, Sabin president, were featured in a great piece on Forbes today.

Forbes contributor highlights Global Network and the Sabin PDP in feature article on NTDs

November 9, 2011

How pharmaceutical companies can help take the 'neglected' out of neglected tropical diseases (NTDs)
By Sarika Bansal

What do schistosomiasis, cysticercosis, and lymphatic filariasis have in common?

Besides verging on the unpronounceable, they are all classified as neglected tropical diseases (NTDs). NTDs are a set of diseases – seventeen, by the World Health Organization’s count – that collectively affect over a billion people, but have historically received little attention.

Started in 2009, World Pneumonia Day was launched by a broad coalition of public and nonprofit organizations—including the Sabin Vaccine Institute and

Second article in VOA NTD news series: Billion people suffer from neglected tropical diseases

November 8, 2011 | Voice of America

By Vidushi Sinha

A billion people around the world suffer from neglected tropical diseases, and the global health community is working to develop new drugs, vaccines and diagnostics. But experts note that success is uneven in part because of different rules and regulations in different countries for drug development and testing.

...

Dr. Peter Hotez, president of Sabin Vaccine Institute, says it is much easier to test new therapies in India than in other parts of the world.

Voice of America

This is the second post in a blog mini-series from the Dengue Vaccine Initiativeabout the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Dr. Peter Hotez featured in a video interview with Voice of America

November 3, 2011

Neglected Diseases Afflict S. Asia's Poor
By Vidushi Sinha

At a time when economists predict that South Asia's economy will grow, health experts point to hundreds of millions suffering from neglected infections, often as a result of poverty. In a series of new studies, researchers say many countries in South Asia bear a disproportionate burden of these diseases and have a need for new drugs and vaccines.

Voice of America

This is the first of a blog mini-series from the Dengue Vaccine Initiative about the collaborative work being done to ensure future access to dengue vaccines in developing nations.

Pages